Managers
UK private equity house Maven Capital Partners has invested GBP1 million in ebb3, with the potential for an additional GBP0.5 million of follow-on funding.
ebb3 is a technology services business operating in a niche part of the high performance computing market. It delivers data intensive 3D graphical applications to customers on any device using High Performance Virtual Computers (HPVCs) and its solutions negate the need for businesses to maintain and run traditional fixed location computer workstations across their organisations.
ebb3’s technology is able to drive heavyweight applications for the likes of computer assisted design (CAD) or computer generated
Peapack-Gladstone Financial Corporation, parent company of Peapack-Gladstone Bank, is to acquire New Jersey-based Murphy Capital Management (MCM).
After up front transaction costs, the purchase will be immediately accretive to earnings.
Doug Kennedy, president and chief executive officer of Peapack-Gladstone Bank, says: “We have found what we feel is the perfect match with MCM and are thrilled this leader in the wealth management space, that shares our geography, will partner with us by joining our private wealth management team.”
Founded in 1983 by John J. Murphy, MCM adheres to a sophisticated and objective method to creating wealth and
Private equity firm Irving Place Capital (IPC) has agreed to sell thermal technology company Chromalox to Spirax-Sarco Engineering, a UK-based company specialising in the control and efficient use of steam and other industrial fluids, for USD415 million in cash.
Completion of the transaction is subject to customary closing conditions.
Chromalox is a technology company that delivers temperature management and process heating solutions for customers in a diverse range of industrial markets.
Chromalox was founded in 1917 and is headquartered in Pittsburgh, PA. IPC acquired Chromalox in December 2012.
“It has been a pleasure to work with
Bluebee, a provider of high-performance genomics analysis and storage solutions, and MediSapiens, a biomedical big data curation, management and interpretation company, have formed a partnership to provide customers with analytical solutions for next generation sequencing data.
Sequencing technology is maturing and being optimised for performance, while becoming increasingly affordable. This has opened an era of reliable and foreseeable quality data growth, which demands high computational resources and data storage capabilities to be combined with best in class data interpretation tools.
MediSapiens’ Explorer Platform is now integrated with the Bluebee platform, offering researchers and clinicians the ability to efficiently
Direct Healthcare Group (DHG) has completed its second bolt-on acquisition in 12 months after acquiring Kirton Healthcare, a UK manufacturer of specialist seating products, from NVM Private Equity.
Based in Caerphilly, DHG specialises in the development of clinically effective solutions for harm-free patient care. With 190 employees and turnover of GBP21 million, the group consists of pressure area care business Direct Healthcare Services and bariatric rental specialist, Nightingale Care Beds.
The acquisition of Kirton Healthcare is the group’s second bolt-on since private equity firm NorthEdge Capital supported an MBO in April 2016.
Kirton, based in Haverhill, has
UK private equity investor LDC has exited its investment in international hosting group UK2 in a sale to The Hut Group (THG), one of the world’s largest online health and beauty retailers and brand owners.
The transaction value has not been disclosed.
LDC originally backed a management buyout of the UK2 Group in 2011 from Cloud Group, supporting the expansion of its portfolio of hosting products whilst accelerating the development of its added-value 100TB offering.
The sale does not include UK2 Group’s US based e-sports business, Digital Chaos, which remains under LDC’s ownership.
THG says the
UK law firm Shepherd and Wedderburn has acted for Safestay in its GBP18.4 million debt restructuring and refinancing with HSBC.
The Shepherd and Wedderburn team also acted for the group in completing sale and leaseback transactions on Safestay’s hostels in Edinburgh and London’s Elephant & Castle.
Those transactions raised gross cash proceeds of GBP12.6 million.
Safestay is best known as a provider of premium affordable tourist accommodation in city centre hostels across Europe.
Scott Ritchie, partner in Shepherd and Wedderburn’s real estate team, says: “The combined drive and ambition of Safestay is truly impressive, and we are delighted
From a structuring perspective, infrastructure funds are most frequently established as either a limited partnership or a limited company. Partnerships are the familiar vehicle for private funds, whereas companies will be used for listed vehicles.
Obviously there will be nuances, depending on the asset class and the type of investors being targeted. “You can give limited companies characteristics that resemble a limited partnership, particularly in offshore jurisdictions like Guernsey, but generally it will be one of the two options described,” says Craig Cordle (pictured), investment funds Group Partner from Ogier in Guernsey.
There are some inherent difficulties with infrastructure funds,
PNC Bank has closed a USD37 million senior secured credit facility for Derby Fabricating Solutions, a portfolio company of Prophet Equity Management.
PNC Capital Markets led the syndication as sole lead arranger, with PNC Bank serving as administrative agent. Steel City Capital Funding, a division of PNC Bank, provided a portion of the financing.
Based in Louisville, Kentucky, Derby Fabricating Solutions is a converter and fabricator of foam and other non-metallic sealing, noise vibration and harshness abatement components primarily servicing North American automotive suppliers.
Derby will use the funds, in part, for its acquisition by Prophet, and to
Life sciences venture capital fund Pappas Capital’s new fund Pappas Ventures V has invested in OrphoMed, a clinical stage company that is developing therapies for treatment of inadequately-controlled gastrointestinal disorders.
The investment in OrphoMed is the first investment by the new Pappas Ventures fund.
The USD39 million Series A funding round was led by New Enterprise Associates and also included Takeda Ventures, Relativity Healthcare Partners and the Mario Family Fund.
OrphoMed’s lead programme is aimed at treating irritable bowel syndrome with diarrhoea (IBS-D), a disorder that affects the intestinal tract and causes cramping, abdominal pain, bloating, gas
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
